logo
  

United Natural Foods Affirms FY22 Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, United Natural Foods, Inc. (UNFI) affirmed its earnings, adjusted earnings and sales guidance for the full-year 2021.

For fiscal 2022, the company continues to project earnings in the range of $3.60 to $3.90 per share and adjusted earnings in the range of $3.90 to $4.20 per share on net sales between $27.8 billion and $28.3 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.09 per share on net sales of $28.02 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT